CIBIDORF

This brand name is authorized in Nigeria.

Active ingredients

The drug CIBIDORF contains one active pharmaceutical ingredient (API):

1	Ciprofloxacin UNII 4BA73M5E37 - CIPROFLOXACIN HYDROCHLORIDE
	Ciprofloxacin is a fluoroquinolone antibacterial agent. The bactericidal action of ciprofloxacin results from the inhibition of both type II topoisomerase (DNA-gyrase) and topoisomerase IV, required for bacterial DNA replication, transcription, repair and recombination.
	Read more about Ciprofloxacin

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A4-5469	Tablet	CIBIDORF TABLET TAB 500 mg 1 X 10	126 RNW-PP-303666 CIBIDORF TABLET CIPROFLOXACIN HYDROCHLORIDE00000 CIPROFLOXACIN HYDROCHLORIDE 500MG A4-5469 Drugs Nigerian Products 110 POM 1 1/16/2023 ORFEMA PHARMACEUTICAL INDUSTRY LIMITED, 5, ATILADE ADEBOWALE STREET, OFF DADDY SAVAGE ROAD, OFF IJU ROAD 14537852 info@orfema.com ORFEMA PHARMACEUTICAL INDUSTRY LIMITED, 5, ATILADE ADEBOWALE STREET, FAGBA – IJU, LAGOS STATE. , Nigeria	21/12/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01MA02	Ciprofloxacin	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01M Quinolone antibacterials → J01MA Fluoroquinolones
Discover more medicines within J01MA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A4-5469